A. Chompret, The Li???Fraumeni syndrome, Biochimie, vol.84, issue.1, pp.75-82, 2002.
DOI : 10.1016/S0300-9084(01)01361-X
URL : https://hal.archives-ouvertes.fr/inserm-00128004

J. Varley, Germline TP53 Mutations and Li-Fraumeni Syndrome, Human Mutation, vol.21, issue.5, pp.313-333, 2003.
DOI : 10.1002/humu.10218

G. Bond, W. Hu, and E. Bond, A Single Nucleotide Polymorphism in the MDM2 Promoter Attenuates the p53 Tumor Suppressor Pathway and Accelerates Tumor Formation in Humans, Cell, vol.119, issue.5, pp.591-602, 2004.
DOI : 10.1016/j.cell.2004.11.022

G. Bond, W. Hu, and A. Levine, A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect, Cancer Research, vol.65, issue.13, pp.5481-5485, 2005.
DOI : 10.1158/0008-5472.CAN-05-0825

P. Dumont, J. Leu, D. Pietra, and A. , The codon 72 polymorphic variants of p53 have markedly different apoptotic potential, Nature Genetics, vol.33, issue.3, pp.357-65, 2003.
DOI : 10.1038/ng1093

L. Donehower, p53: guardian AND suppressor of longevity?, Experimental Gerontology, vol.40, issue.1-2, pp.7-9, 2005.
DOI : 10.1016/j.exger.2004.10.007

A. Martin, P. Kanetsky, and B. Amirimani, Germline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1?, Journal of Medical Genetics, vol.40, issue.4, p.34, 2003.
DOI : 10.1136/jmg.40.4.e34

J. Flaman, T. Frebourg, and V. Moreau, A simple p53 functional assay for screening cell lines, blood, and tumors., Proceedings of the National Academy of Sciences, vol.92, issue.9, pp.3963-3970, 1995.
DOI : 10.1073/pnas.92.9.3963

A. Chompret, L. Brugieres, and M. Ronsin, P53 germline mutations in childhood cancers and cancer risk for carrier individuals, Br J Cancer, vol.82, pp.1932-1939, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00117136